Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
1.
Adv Mater ; : e2404120, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38727702

ABSTRACT

This study innovatively addresses challenges in enhancing upconversion efficiency in lanthanide-based nanoparticles (UCNPs) by exploiting Shewanella oneidensis MR-1, a microorganism capable of extracellular electron transfer. Electroactive membranes, rich in c-type cytochromes, are extracted from bacteria and integrated into membrane-integrated liposomes (MILs), encapsulating core-shelled UCNPs with an optically inactive shell, forming UCNP@MIL constructs. The electroactive membrane, tailored to donate electrons through the inert shell, independently boosts upconversion emission under near-infrared excitation (980 or 1550 nm), bypassing ligand-sensitized UCNPs. The optically inactive shell restricts energy migration, emphasizing electroactive membrane electron donation. Density functional theory calculations elucidate efficient electron transfer due to the electroactive membrane hemes' highest occupied molecular orbital being higher than the valence band maximum of the optically inactive shell, crucial for enhancing energy transfer to emitter ions. The introduction of a SiO2 insulator coating diminishes light enhancement, underscoring the importance of unimpeded electron transfer. Luminescence enhancement remains resilient to variations in emitter or sensitizing ions, highlighting the robustness of the electron transfer-induced phenomenon. However, altering the inert shell material diminishes enhancement, emphasizing the role of electron transfer. This methodology holds significant promise for diverse biological applications. UCNP@MIL offers an advantage in cellular uptake, which proves beneficial for cell imaging.

2.
Oncol Rep ; 40(5): 3112, 2018 11.
Article in English | MEDLINE | ID: mdl-30226621

ABSTRACT

We wish to retract our research article entitled "Long non­coding RNA MALAT1 interacts with miR­124 and modulates tongue cancer growth by targeting JAG1" published in Oncology Reports 37 2087­2094, 2017. Following the publication of this article, it was drawn to our attention that this paper bore numerous similarites with an article published previously in the journal OncoTargets and Therapy. Although all the data reported in our study were original, we recognize that it was not appropriate that we should have modelled our paper on previously published articles as a template on which to base the writing of our paper. Therefore, we have agreed to follow the Editor's recommendation that this paper be retracted from the publication. All the named authors agree to this retraction. We sincerely apologize to the Editor and the readership of the Journal for our action, and regret any inconvenience this has caused. [the original article was published in the Oncology Reports 37: 2087­2094, 2017; DOI: 10.3892/or.2017.5445].

3.
Oncol Lett ; 15(6): 9959-9964, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29928368

ABSTRACT

Distant metastasis represents the outcome with the worst prognosis for various types of malignant tumors, but little is known regarding the impact of interacting epithelial and mesenchymal phenotypic cancer cells within its etiopathogenesis. In a novel animal model, 48 male athymic Balb/c nude mice underwent subcutaneous and intravenous injection of human tongue cancer cell lines of green fluorescent mesenchymal and red fluorescent epithelial phenotypes, in order to visualize and monitor eventual phenotypic interaction in lung metastasis as well as experimental metastasis in in vivo, ex vivo and histopathological analyses. While the epithelial, but not the mesenchymal, phenotypic human tongue cancer cell line led to direct metastasis in the lungs when injected intravenously, neither of them, even when injected in combination, were able to establish distant metastasis. The results of the present study provide evidence regarding the role of epithelial phenotypic cancer cells in the release of experimental metastasis following tail vein injection in male athymic Balb/c nude mice, in addition to proving fluorescent human tongue cancer cells may be reliably detected under a fluorescence microscope even 8 weeks after the two injection types.

4.
Exp Ther Med ; 14(4): 3393-3398, 2017 Oct.
Article in English | MEDLINE | ID: mdl-29042924

ABSTRACT

Cleft palate is a common craniofacial birth defect. The aim of the present study was to investigate the effect of excess all-trans retinoic acid (atRA) on periderm removal and the disappearance of basal medial edge epithelial (MEE) cells during palatogenesis, particularly during the stage prior to contact. atRA (200 mg/kg) was administered to C57BL/6N mice at embryonic day (E) 12.0 by gavage. Fetal palates were processed and analyzed by histology and electron microscopy. Single palate shelf peridermal cells were removed and cultured in the presence of atRA (3 µM) only or in the presence of or the caspase inhibitor, Z-VAD (100 µM) only, for 48 h. Once cultured, morphological changes were analyzed by histological staining and electron microscopy. A TUNEL assay was used to detect apoptotic neurons. Paired palatal shelves with periderm removal were cultured in the presence of atRA (3 µM) only or in the presence of Z-VAD (100 µM) only for 48 h and analyzed by hematoxylin and eosin staining. At E14.5, medial edge epithelium periderm was retained in the atRA-treated palates but had been shed prior to contact in the control groups. In addition, atRA was revealed to disrupt the cell cycle in the periderm by downregulating p21. Furthermore, atRA inhibited apoptosis in the periderm and basal MEE cells; however, atRA exhibited no effect on basement membrane degradation in single palatal organ culture. Additionally, once paired palates were cultured for 48 h, all of the groups in which the periderm had been removed exhibited confluence of the embryonic palatal mesenchyme. The present results suggest that periderm removal is inhibited in atRA-induced cleft palate in mice and that removal of the periderm contributes to EPM confluence in vitro.

5.
Oncol Rep ; 37(4): 2087-2094, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28260102

ABSTRACT

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long non-coding RNA (lncRNA), was the earliest discovered to be correlated with cancer and contributes to the initiation and development of several types of tumors. Dysregulation of MALAT1 expression is frequently observed in many types of cancer such as gastric cancer, esophageal squamous cell carcinoma and glioma. To date, the role of MALAT1 and the underlying mechanisms in tongue cancer development remain unclear. In the present study, we studied the influence of MALAT1 on tongue cancer cell lines and clinical tongue cancer samples so as to detect its function and the underlying mechanism. In the present study, lncRNA-MALAT1 was specifically upregulated in tongue cancer cell lines and overexpression promoted tongue cancer cell growth by targeting miR-124. Knockdown of MALAT1 suppressed the growth and invasion of human tongue cancer cells and inhibited metastasis in vitro and in vivo. In addition, miR-124-dependent jagged1 (JAG1) regulation was required for MALAT1-induced tongue cancer cell growth. Our data revealed that MALAT1 inhibited tongue cancer cell growth and metastasis through miR-124-dependent JAG1 regulation. In conclusion, we revealed that MALAT1 may play an oncogenic role by increasing proliferation and metastasis of tongue cancer and is a potential therapeutic target in human tongue cancer.


Subject(s)
Jagged-1 Protein/biosynthesis , MicroRNAs/biosynthesis , RNA, Long Noncoding/genetics , Tongue Neoplasms/genetics , Apoptosis/genetics , Cell Line, Tumor , Cell Proliferation/genetics , Female , Gene Expression Regulation, Neoplastic , Humans , Jagged-1 Protein/genetics , Male , MicroRNAs/genetics , RNA, Long Noncoding/metabolism , Tongue Neoplasms/pathology
6.
Arch Oral Biol ; 79: 48-54, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28288391

ABSTRACT

OBJECTIVES: This study investigated the phenotypic stability and biological properties of two human tongue cancer cell lines after transduction of fluorescent proteins. DESIGN: The human tongue cancer cell lines UM1 and UM2 were cultured with GFP and RFP lentiviral particles stock for 72h. Cells with successful transduction of fluorescent proteins were selected in a medium containing G418 antibiotics for two weeks. The proliferation rates of parental and transduced cell lines were evaluated by their population doubling time (PDT). Transduction efficiency was assessed by fluorescence microscope and flow cytometry. The transduced cells in passage 1, 2, 10, 20 and 30 were collected to check the stability of fluorescent protein expression. Phenotypic stability of the transduced cells was detected by means of cell morphology, cell surface markers and cell function evaluating essay. RESULTS: The proliferation rates of the transduced cell lines showed no significant difference compared to their parental cells. Successful transduction with high efficiency (99% up) was demonstrated. High fluorescence expression on both transduced cells was detected until the thirtieth generation. UM1 and UM1-GFP displayed mesenchymal cell characteristics, while UM2 and UM2-RFP cell lines showed properties characteristic of epithelial. CONCLUSIONS: Two human tongue cancer cell lines of epithelial and mesenchymal phenotype respectively, have been successfully labelled with green and red fluorescent proteins. The fluorescence maintained a high expression rate over thirty generations without influencing the original morphological phenotype and cadherin expression.


Subject(s)
Luminescent Proteins/genetics , Phenotype , Tongue Neoplasms/genetics , Tongue Neoplasms/pathology , Transduction, Genetic , Cell Line, Tumor , Cell Movement , Cell Proliferation , Epithelium/pathology , Flow Cytometry , Genetic Vectors , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Lentivirus/genetics , Luminescent Proteins/metabolism , Membrane Proteins , Mesenchymal Stem Cells/cytology , Tongue Neoplasms/metabolism , Red Fluorescent Protein
7.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-822337

ABSTRACT

@#With the development of computer science and biotechnology, medical data has been dramatically increased and demonstrated the properties of variety and complexity. Biological and clinical researchers now face increasingly large and complex data sets. In the era of big data, strategies of diagnosis and treatment of cancer are gradually changed from evidence-based medicine to precision medicine. The promise of the big data paradigm may affect patients with oral cancer by enabling personalized monitoring, diagnosis and treatment. In this article, we will review the advances of diagnosis and treatment modality in oral cancer based on big data platform, which is mainly focused on oral cancer screening, early detection, molecular classification, prediction of metastasis and chemosensitivity.

8.
Biomed Res Int ; 2016: 4897986, 2016.
Article in English | MEDLINE | ID: mdl-27957498

ABSTRACT

Tumorigenicity and metastatic activity can be visually monitored in cancer cells that were labelled with stable fluorescence. The aim was to establish and validate local and distant spread of subcutaneously previously injected fluorescence transduced human tongue cancer cell lines of epithelial and mesenchymal phenotype in nude mice. A total of 32 four-week-old male athymic Balb/c nude mice were randomly allocated into 4 groups (n = 8). A single dose of 0.3 mL PBS containing 1 × 107 of four different cancer cell-lines (UM1, UM1-GFP, UM2, and UM2-RFP) was injected subcutaneously into the right side of their posterolateral back. Validity assessment of the labelled cancer cells' tumorigenicity was assessed by physical examination, imaging, and histology four weeks after the injection. The tumor take rate of cancer cells was similar in animals injected with either parental or transduced cancer cells. Transduced cancer cells in mice were easily detectable in vivo and after cryosection using fluorescent imaging. UM1 cells showed increased tumor take rate and mean tumor volume, presenting with disorganized histopathological patterns. Fluorescence labelled epithelial and mesenchymal human tongue cancer cell lines do not change in tumorigenicity or cell phenotype after injection in vivo.


Subject(s)
Carcinogenesis/pathology , Epithelium/pathology , Fluorescent Dyes/metabolism , Mesoderm/pathology , Mouth Neoplasms/pathology , Animals , Carcinogenesis/metabolism , Cell Line, Tumor , Cell Proliferation , Cryoultramicrotomy , Green Fluorescent Proteins/metabolism , Humans , Male , Mice, Inbred BALB C , Mice, Nude , Reproducibility of Results , Subcutaneous Tissue/pathology , Xenograft Model Antitumor Assays
9.
Biomed Res Int ; 2016: 5378567, 2016.
Article in English | MEDLINE | ID: mdl-27529071

ABSTRACT

Abnormal expression of ß-catenin contributes to tumor development, progression, and metastasis in various cancers. However, little is known about the relationship between abnormal expression of ß-catenin and cisplatin chemotherapy in oral squamous cell carcinoma (OSCC). The present study aimed to investigate the effect of ß-catenin on OSCC cisplatin resistance and evaluated the drug susceptibility of stable cell lines with ß-catenin knockin and knockdown. In this study, we found that higher expression level of ß-catenin can be observed in CDDP-treated cell lines as compared with the control group. Furthermore, the expression levels of ß-catenin increased in both a concentration- and time-dependent manner with the cisplatin treatment. More importantly, the nuclear translocation of ß-catenin could also be observed by confocal microscope analysis. Stable cell lines with CTNNB1 knockin and knockdown were established to further investigate the potential role and mechanism of ß-catenin in the chemoresistance of OSCC in vitro and in vivo. Our findings indicated that overexpression of ß-catenin promoted cisplatin resistance in OSCC in vitro and in vivo. We confirmed that GSK-3ß, C-myc, Bcl-2, P-gp, and MRP-1 were involved in ß-catenin-mediated drug resistance. Our findings indicate that the Wnt/ß-catenin signaling pathway may play important roles in cisplatin resistance in OSCC.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Cisplatin/pharmacology , Drug Resistance, Neoplasm , Gene Expression Regulation, Neoplastic , Mouth Neoplasms/metabolism , Neoplasm Proteins/metabolism , beta Catenin/biosynthesis , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Humans , Mouth Neoplasms/drug therapy , Mouth Neoplasms/genetics , Mouth Neoplasms/pathology , Neoplasm Proteins/genetics , Wnt Signaling Pathway/drug effects , Wnt Signaling Pathway/genetics , beta Catenin/genetics
10.
Chin J Dent Res ; 19(1): 25-33, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26981604

ABSTRACT

Oral cancer is an aggressive disease with the propensity for local recurrence and distal metastasis in the head and neck region. Currently, cisplatin-based chemotherapy or concurrent radiochemotherapy is still the first choice to treat the advanced stage cancers, in particular, the unresectable tumours. Unfortunately, innate and acquired resistance to chemotherapy agent greatly limited its effectiveness and often led to treatment failure in these patients. Hence, it is urgent to clarify the mechanisms underlying the development of chemoresistance in patients with oral cancer. In this article, the current understandings on molecular mechanisms of chemoresistance in oral cancer were reviewed, including drug efflux, apoptosis, DNA damage and repair, epithelial mesenchymal transition, autophagy and miRNA.


Subject(s)
Antineoplastic Agents/therapeutic use , Drug Resistance, Neoplasm/genetics , Mouth Neoplasms/genetics , Apoptosis/genetics , Autophagy/genetics , DNA Damage/genetics , DNA Repair/genetics , Epithelial-Mesenchymal Transition/genetics , Humans , MicroRNAs/genetics , Mouth Neoplasms/drug therapy , Multidrug Resistance-Associated Proteins/genetics
11.
Zhongguo Zhong Yao Za Zhi ; 39(5): 821-7, 2014 Mar.
Article in Chinese | MEDLINE | ID: mdl-25204172

ABSTRACT

To prepare the hawthorn leaves flavonoids self-microemulsifying membrane controlled-release coated drop pill, and to study its release rate in vitro and pharmacokinetics study in vivo. In order to improve the dissolution of hawthorn leaves flavonoids, self-microemulsifying technology was used to prepare the hawthorn leaves flavonoids self-microemulsion. Hawthorn leaves flavonoids self-microemulsifying drop pill was prepared with the PEG 6000. Studies were made on the in vitro release of flavonoids from hawthorn leaves self-micro-emulsifying membrane-moderated coated drop pills and the in vivo pharmacokinetic in rats. The prescription of flavonoids from hawthorn leaves self-micro-emulsifying drop pills was 0.25 g of flavonoids from hawthorn leaves, 0.25 g of iodophenyl maleimide, 0.375 g of polyethylene glycol 400, 0.375 g of cremophor RH 40 and 2 g of polyethylene glycol 6000. The optimized prescription was 4 g of ethyl cellulose 20, 0.64 g of polyethylene glycol 400, 1.8 g of diethyl phthalate, and the weight of coating materials increased by 3.5%. Flavonoids from hawthorn leaves self-micro-emulsifying membrane-moderated coated drop pills complied with the design of sustained-release in 12 h in terms of in vitro release and in vivo pharmacokinetic parameters in rats, and its bioavailability was 2.47 times of quick-release drop pills. Slightly soluble flavonoids from hawthorn leaves could be made into sustained-release preparations by the self-micro-emulsifying and coating technology.


Subject(s)
Crataegus/chemistry , Delayed-Action Preparations/pharmacokinetics , Drugs, Chinese Herbal/pharmacokinetics , Flavonoids/pharmacokinetics , Animals , Chemistry, Pharmaceutical , Delayed-Action Preparations/chemistry , Drugs, Chinese Herbal/chemistry , Flavonoids/chemistry , Male , Plant Leaves/chemistry , Rats , Rats, Sprague-Dawley
12.
J Oral Pathol Med ; 42(4): 322-31, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23157415

ABSTRACT

BACKGROUND: The changes in Notch signaling are closely related to the occurrence and development of many cancers. We have investigated Notch signaling receptor and its ligand expressions in TSCC cell lines, tissues and its significance. We clarified Notch signaling pathway in TSCC and its mechanism. We regulated Notch signaling pathway of tumor cells, thereby inhibiting tumor cell proliferation and differentiation. METHODS: We detected Jagged1 protein and mRNA expression levels in specimens (tongue cancer and adjacent tissues) from 74 patients with tongue cancer and in TSCC cell line. The Jagged1-targeted lentiviral vector RNAi system was constructed, and its suppressive effects on the proliferation and invasion of tongue carcinoma cells in in vivo and ex vivo were determined. RESULTS: Jagged1 was expressed in tongue squamous cell cancer tissues and cell line, but there were differences in its expression. Jagged1 was knocked down and the tumor growth was inhibited accompanying cell cycle changes. Animal studies also showed that the tumor growth was inhibited. CONCLUSIONS: Jagged1 may be involved in the differentiation and proliferation of tongue cancer. Targeting Jagged1 RNA interference lentiviral vector can effectively lower Jagged1 mRNA and protein expression levels of Tca8113 cells, thereby preventing the proliferation of TSCC cells. Jagged1 is expected to be a promising new target for curing tongue cancer. In-depth study of the interaction between Jagged1 and other molecules of Notch signaling pathway in the process of carcinogenesis has important theoretical guidance and clinical significance in revealing the mechanism of Jagged1 and its application in the therapy for tongue cancer.


Subject(s)
Calcium-Binding Proteins/antagonists & inhibitors , Carcinoma, Squamous Cell/pathology , Membrane Proteins/antagonists & inhibitors , Tongue Neoplasms/pathology , Animals , Calcium-Binding Proteins/genetics , Carcinoma, Squamous Cell/genetics , Cell Culture Techniques , Cell Cycle/genetics , Cell Differentiation/genetics , Cell Line, Tumor , Cell Proliferation , Cell Survival/genetics , Cell Transformation, Neoplastic/genetics , Female , Gene Expression Regulation, Neoplastic/genetics , Gene Knockdown Techniques , Gene Transfer Techniques , Genetic Vectors/genetics , Humans , Intercellular Signaling Peptides and Proteins/genetics , Jagged-1 Protein , Lentivirus/genetics , Membrane Proteins/genetics , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , RNA Interference , RNA, Small Interfering/genetics , Serrate-Jagged Proteins , Signal Transduction/genetics , Skin Neoplasms/pathology , Tongue Neoplasms/genetics
14.
Article in Chinese | MEDLINE | ID: mdl-22800344

ABSTRACT

OBJECTIVE: To evaluate the outcome and indication of the reconstruction of oral and maxillofacial postoperative defects by submental artery island myocutaneous flaps. METHODS: Sixty eight cases with the reconstruction of oral and maxillofacial defects by submental artery island myocutaneous flaps from January 2006 to May 2010 were analysed retrospectively. Primary lesions included carcinomas originating from tongue (28 cases), palate (13 cases), mouth floor (9 cases), gingiva (4 cases), buccal mucosa (6 cases), lip (3 cases), and other malignant or benign tumors (5 cases). The ages ranged from 25 to 84 years (mean 58 years); 47 males and 21 females. The sizes of skin paddle varied from a minimum of 4 cm × 4 cm to a maximum of 15 cm × 10 cm. RESULTS: Of the 68 flaps, 62 were survival, 4 had partial necrosis but healed with treatments, and 2 failed due to complete necrosis. Appearance and functions of recipient sites were satisfactory. The followed-up time was 3 - 24 months, local recurrence occurred in 5 cases and cervical lymph node metastases were found in 15 patients. CONCLUSION: Submental island flap is reliable for the reconstruction of postoperative defects in early oral cancer without regional lymph node metastasis or in benign tumor.


Subject(s)
Carcinoma, Squamous Cell/surgery , Mouth Neoplasms/surgery , Plastic Surgery Procedures/methods , Surgical Flaps , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Retrospective Studies , Skin Transplantation
15.
J Craniomaxillofac Surg ; 40(8): e432-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22484124

ABSTRACT

OBJECTIVE: The purpose of this clinical study was to explore the optimal method of reconstruct mandible defects individually and immediately. STUDY DESIGN: Three-dimensional model simulation technique and vascularized fibular osteomyocutaneous flap were used to repair 15 cases of mandible defects, which were caused by ameloblastoma. A three-dimensional computed tomography (CT) images were converted to a virtual model using CAD software and the 3-dimensional (3D) simulated resin models of skeleton and fibula were used to design the osteotomies, bone segment replacement and titanium mesh shaping preoperatively. RESULTS: Fibula flaps were alive and no complication occurred. The patients were satisfied with the results both esthetically and functionally. CONCLUSIONS: This preliminarily clinical study and case demonstrated that CAD/CAM-assisted technique with surgical treatment offers an individual anatomical reconstruction of the mandible in ameloblastoma patients. The procedures guarantee intraoperatively an exact placement of the preformed mesh even for precise reconstruction of extensive mandible defects.


Subject(s)
Computer-Aided Design , Mandibular Reconstruction/methods , Plastic Surgery Procedures/methods , Adult , Ameloblastoma/surgery , Bone Transplantation/methods , Computer Simulation , Esthetics , Female , Fibula/surgery , Graft Survival , Humans , Imaging, Three-Dimensional/methods , Male , Mandible/surgery , Mandibular Neoplasms/surgery , Middle Aged , Models, Anatomic , Muscle, Skeletal/transplantation , Osteotomy/methods , Patient Care Planning , Patient Satisfaction , Skin Transplantation/methods , Surgical Flaps/transplantation , Surgical Mesh , Tomography, X-Ray Computed/methods , User-Computer Interface , Young Adult
16.
J Oral Pathol Med ; 41(2): 141-8, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21793937

ABSTRACT

BACKGROUND: Multiple drug resistance protein 1 (MRP1), lung resistance protein (LRP), topoisomerase IIß (TOPOIIß) and B-cell lymphoma 2 (BCL2) are well known in the development of drug resistance in cancer cells. The aim of this study was to evaluate the relationship between them and the clinicopathological features, their expression differences between tumor tissue and experimental drug-resistant model in tongue carcinoma. MATERIALS AND METHODS: Multiple drug resistance protein 1, LRP, TOPOIIß, and BCL2 expression was examined by immunohistochemistry in specimens from radical surgeries of 65 patients with tongue carcinoma. A cisplatin-resistance cell line, SCC-15/cisplatin, was established from a cisplatin-sensitive cell line, SCC-15. A MTT-based method was used to analyze drug potencies. Immunofluorescence was used to detect protein expression in both cell lines. Western blot was used to compare the protein expressions in specimens and SCC-15/cisplatin cells. RESULTS: We found higher expression of MRP1, LRP, and BCL2 and lower expression of TOPOIIß in tongue carcinoma compared with adjacent non-neoplastic tongue tissues (P < 0.05). In addition, MRP1 and TopoIIß expression were significantly associated with clinical stage, lymph node metastasis and histologic grade, and LRP was significantly associated with histologic grade in the samples (P < 0.05). Finally, Western blot showed that higher expressions of MRP1, LRP, and BCL2 and lower expression of TopoIIß were observed in SCC-15/cisplatin cells than in clinical samples. CONCLUSION: Our results suggest that the high expressions of MRP1, LRP, and BCL2 and low expression of TOPOIIß in patients with tongue carcinoma indicates that intrinsic drug resistance may exist in tongue carcinoma, and is associated with tumor differentiation and cisplatin resistance in tongue carcinoma.


Subject(s)
Carcinoma, Squamous Cell/pathology , DNA Topoisomerases, Type II/analysis , DNA-Binding Proteins/analysis , Drug Resistance, Multiple , Multidrug Resistance-Associated Proteins/analysis , Proto-Oncogene Proteins c-bcl-2/analysis , Tongue Neoplasms/pathology , Vault Ribonucleoprotein Particles/analysis , Antineoplastic Agents/pharmacology , Blotting, Western , Carcinoma, Squamous Cell/secondary , Cell Line, Tumor , Cell Shape , Cisplatin/pharmacology , Coloring Agents , Drug Resistance, Neoplasm , Female , Fluorescent Antibody Technique , Humans , Lymphatic Metastasis/pathology , Male , Middle Aged , Neoplasm Grading , Neoplasm Staging , Tetrazolium Salts , Thiazoles , Tongue/pathology
18.
Article in English | MEDLINE | ID: mdl-20708420

ABSTRACT

Progressive hemifacial atrophy is a rare disorder characterized by an acquired, idiopathic, self-limited, unilateral facial atrophy involving skin, subcutaneous tissue, fat, muscle, and bone. Symmetry and contour restoration are the main treatment challenges. Among many techniques, microvascular reconstruction has been introduced as the gold standard to correct the atrophic deformity. For some patients with severe manifestations, soft tissue reconstruction alone does not obtain the desired outcome. In this series, we used an effective method to restore the severe progressive hemifacial atrophy by simultaneous maxillomandibular distraction osteogenesis with 2 distractors. The results demonstrate an improvement in both the profile and the occlusion plane of the patients with corresponding satisfactory esthetic and functional outcomes. We conclude that the simultaneous maxillomandibular distraction osteogenesis with 2 distractors is an effective method for hemifacial atrophy and bone frame reconstruction, especially ones involved in the discrepancy of the occlusal plane.


Subject(s)
Facial Hemiatrophy/surgery , Mandible/surgery , Maxilla/surgery , Osteogenesis, Distraction/instrumentation , Adolescent , Esthetics , External Fixators , Face/surgery , Female , Humans , Male , Microsurgery , Muscle, Skeletal/transplantation , Osteotomy/methods , Osteotomy, Le Fort/methods , Plastic Surgery Procedures , Surgical Flaps , Treatment Outcome , Vascular Surgical Procedures , Young Adult
19.
J Craniomaxillofac Surg ; 39(3): 209-14, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20417110

ABSTRACT

INTRODUCTION: The effect of an initial radical cure and the post-operative quality of life in young patients with stage one or two tongue cancer seems to be more important than in old patients. The aim of this study was to achieve both optimal surgical effectiveness and improved post-operative quality of life for young patients with stage one or two tongue cancer. MATERIALS AND METHODS: 7 patients under 40 years of age with T(1)-T(2)N(0)M(0) squamous cell carcinoma of tongue underwent aesthetic and functional radical surgery in which reconstruction of the defect in the oral cavity and conservation of the main functional organs in neck with good scar aesthetics in the face and neck were performed. The outcomes were assessed clinically. RESULTS: No tumour recurrence was found in the tongue, floor of mouth or neck at the end of follow-up (at least 37 months). The appearance of the tongue and oral function was retained; function in face, neck and shoulder was maintained; a satisfactory cosmetic appearance of the face and neck was achieved. CONCLUSIONS: Aesthetic and functional radical surgery could ensure radical cure and unchanged, or improved post-operative, quality of life in young patients with stage one or two tongue cancer.


Subject(s)
Carcinoma, Squamous Cell/surgery , Oral Surgical Procedures/methods , Plastic Surgery Procedures/methods , Surgical Flaps , Tongue Neoplasms/surgery , Adult , Carcinoma, Squamous Cell/pathology , Esthetics , Female , Fibula/surgery , Humans , Male , Neck Dissection/methods , Neoplasm Staging , Quality of Life , Recovery of Function , Skin Transplantation , Tongue Neoplasms/pathology
20.
Cleft Palate Craniofac J ; 48(2): 197-204, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20500080

ABSTRACT

OBJECTIVE: To determine changes on craniofacial growth morphometrically in newborn mice with cleft palate induced by retinoic acid. DESIGN, SETTING, PARTICIPANTS, INTERVENTIONS: Gestation day 10 or 12 pregnant female C57BL/6N mice were given a single dose of all-trans retinoic acid (atRA) by gastric intubations via oral gavage. Sixty newborn mice with cleft palate (CP), 52 without CP from the experimental group, and 30 without CP from the control group were collected, and lateral cephalograms were taken of all of the mice. MAIN OUTCOME MEASURES: Cephalometric analysis of the craniofacial skeleton was performed by means of a personal computer. RESULTS: Inhibition of craniofacial growth was found in the experimental groups but not in the control groups. In the maxillary bone and mandible, the amount of growth was significantly reduced. CONCLUSIONS: These results suggest that craniofacial growth is inhibited in newborn mice with cleft palate induced by retinoic acid.


Subject(s)
Cephalometry/methods , Cleft Palate/diagnostic imaging , Craniofacial Abnormalities/diagnostic imaging , Tretinoin/toxicity , Animals , Animals, Newborn , Cleft Palate/chemically induced , Craniofacial Abnormalities/chemically induced , Embryo, Mammalian/drug effects , Female , Fetus/drug effects , Gestational Age , Mice , Mice, Inbred C57BL , Pregnancy , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...